Edwards Lifesciences Corp Earnings Report Preview For Tuesday's Release (EW)
Edwards Lifesciences Corp (NYSE:EW) will be releasing last fiscal quarter's results after the closing bell on April 24, 2012. We can review how Edwards Lifesciences Corp has executed for investors recently.
Who They Are:
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases or critically ill patients worldwide. The company was founded in 1999 and is headquartered in Irvine, California. Edwards Lifesciences Corp trades an average of 1.2 million shares per day and has a marketcap of $8.2 Billion.
Book Value: $11.73
Float Short: 3.23%
What To Expect:
On average, 19 Analysts are expecting a drop of $-0.14 in earnings per share compared to last quarter's results of $0.62. The estimated mean earnings are $0.48 per share .
Analyst estimates range between $0.44 and $0.50 per share.
Here is a look at the fiscal year revenue for Edwards Lifesciences Corp.
Recent Stock and Valuation Performance:
The P/E ratio has come down, as the current trailing twelve months P/E ratio is 35.3, while the forward P/E ratio is now 26.82. An upside earnings report may provide greater wind in the sails.
In the last month, the stock has increased in price 0.31%, with a change from a year ago of -12.54%.
When comparing to the S&P 500, the year to date difference is -8.72%.
Revenue growth relative to last year appears to be problematic for management. Comparing year-over-year fiscal years, revenue has declined to $1.68 billion for 2011 vs. $1.45 billion for 2010. The bottom line has rising earnings year-over-year of $236.70 million for 2011 vs. $218.00 million for 2010.The company's earnings before interest and taxes are rising with an EBIT year-over-year of $278.50 million for 2011 vs. $261.60 million for 2010. Rising revenue along with rising earnings is a very good sign and what we want to see with our companies. Be sure to check the margins in the earnings release to make sure the bottom line is keeping up with the top line.
Here are the last few quarters to get an idea how well they perform compared to estimates
Reported earnings per share compared to the mean estimate. Differences are rounded.
Paid2Trade uses information believed to be correct, but is not guaranteed and is not independently checked for accuracy You may wish to use this article as a starting point of your own research with your financial planner. Seeking Alpha, Edgar Online, Zacks and Yahoo Finance provides most of the data. paid2trade.com uses the "confirmed" symbols from earnings.com that believed to be of the most interest.